Overview
Celtic Pharma Portfolio Overview
Celtic Pharma currently has a portfolio of eight novel, highly differentiated, late-stage biopharmaceutical products. Each product is being developed to address important unmet medical needs. Celtic Pharma's goal is to move these products rapidly through their clinical and regulatory development while continuing to build a diversified portfolio